Company Overview

PRIME exits® and American HealthCare Capital are pleased to exclusively present an established, multi-state Applied Behavior Analysis (“ABA”) therapy provider for sale. The Company delivers in-home, community-based, and clinic-based therapy to children and adolescents with autism spectrum disorder and related developmental disabilities. Known for its clinical excellence and individualized approach, the platform has developed strong relationships with families, referral sources, and commercial payers across its growing geographic footprint.

The Company serves more than 300 patients annually, with approximately 95 percent of services delivered in-home. This service model creates high levels of family engagement and supports superior clinical outcomes. Therapy is delivered on a one-to-one basis by experienced BCBAs and RBTs, supported by a highly trained management and clinical leadership team. Demand continues to exceed available staffing, underscoring the strength of the brand and the unmet need in its markets.

Payer Relationships

The Company is in-network with many major commercial insurers, including Blue Cross Blue Shield, Aetna, Cigna, Tricare, and several regional carriers. Medicaid participation is limited and represents only a small fraction of total revenue. Recent investments in billing infrastructure and the engagement of a specialized third-party billing partner have significantly improved collections, enhancing both revenue capture and cash flow predictability.

Financial Performance

The platform has demonstrated strong growth and profitability, with revenue increasing from approximately $11.6 million in 2023 to $13.6 million in 2024, while adjusted EBITDA expanded from $4.2 million to $5.4 million over the same period. Through the first eight months of 2025, the Company generated $11.2 million in revenue and $5.5 million of adjusted EBITDA, positioning it to achieve a full-year run-rate of $18 million in revenue and $8 million in EBITDA.

Investment Highlights

This opportunity represents a chance to acquire a premier ABA therapy platform with:

• A proven, scalable in-home service model that drives superior outcomes and high patient retention.

• Consistently strong financial performance with expanding margins and robust cash flow.

• A diversified commercial payer base with minimal Medicaid exposure.

• A seasoned leadership team with deep operational and clinical expertise that will remain with the business post-transaction.

Asking Price and Exit Plan

The seller is seeking a full exit at a valuation of $55 million. The seller is open to a transitional role to support integration with new ownership.